Skip to content

Evaluation of the efficacy of Ajamodadya Vataka and Rasnadashamoola Kwatha in the management of Amavata

A Comparative Clinical Study to evaluate the efficacy of Ajamodadya Vataka and Rasnadashamoola Kwatha in the management of Amavata W.S.R to Rheumatoid Arthritis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024188
Enrollment
40
Registered
2020-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

Intervention1: Ajamodadya vataka Rasnadashamoola Kwatha: Ajamodadya vataka( 1 g each) 2 tablets thrice a day orally after food- group A Rasnadashamoola kwatha- 40 ml with 10 ml of eranda taila twice a

Sponsors

National Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to sign consent form for the clinical trial. 2. Patients between the age group of 20 to 60 years, irrespective of sex and socio- economic status. 3. Patients having signs and symptoms of ‘Amavata roga’ according to classical text of Ayurveda as a subjective criteria & according to modern text books w.s.r. Rheumatoid Arthritis as a objective criteria including Seropositive (RA Factor- Positive) as well as Seronegative (RA Factor-Negative) both. 4. Patients with chronicity of less than 5 years.

Exclusion criteria

Exclusion criteria: 1. Patients having severe joint deformities. 2. Patients suffering from paralysis. 3. Patients having any type of arthropathy such as Neoplasm of spine, Gout, Ankylosing spondylosis, Traumatic arthritis and Pyogenic osteomyelitis etc . 4. Patients having associated Cardiac disease, Tuberculosis, Diabetes mellitus, Malignant Hypertension, Renal Function Impairment, Hypothyroidism, RHD etc. 5. Patients with extremely reduced joint space. 6. Pregnant women and lactating mother.

Design outcomes

Primary

MeasureTime frame
Changes in the score of ACR,EULAR criteriaTimepoint: 30 days

Secondary

MeasureTime frame
Changes in the laboratory parameters and the Lakshanas of Amavata like Jwara,Angamarda,Sandhishoola etcTimepoint: 30 days

Countries

India

Contacts

Public ContactProf Ram Kishor Joshi

National Institute Of Ayurveda,Jaipur

joshirk1964@gmail.com9414322297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026